Latest News & Features
Americas
French cell therapy company Cellectis has announced plans to make two CRISPR patents, which were recently granted by the US Patent and Trademark Office, available for licensing. 14 February 2018
Americas
Japan-based Sumitomo Dainippon Pharma has taken on Indian generics company Emcure Pharmaceuticals over an antipsychotic drug. 14 February 2018
Big Pharma
LSIPR attended a packed UK Supreme Court yesterday for day one of a four-day hearing, with Warner-Lambert debating the role that plausibility plays in patent law. Below we provide an overview of the case and its core issues. 13 February 2018
Americas
Global law firm Ropes & Gray has welcomed Filko Prugo to its New York office as partner and chair of the life sciences IP practice. 12 February 2018
Americas
The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9. 12 February 2018
Asia-Pacific
Allergan is set to acquire Australia-based Elastagen, a clinical-stage company focused on developing medical device products based on recombinant tropoelastin, for $95 million. 12 February 2018
Americas
The US Court of Appeals for the Federal Circuit has vacated the rejection of a patent application relating to an elastic knee brace. 9 February 2018
Americas
ViiV Healthcare, which was established by major pharma companies, has filed a patent infringement complaint against Gilead Sciences in a case involving an HIV treatment drug. 9 February 2018
Big Pharma
An advocate general at the Court of Justice of the European Union yesterday backed Pfizer in a dispute over the parallel importation of an arthritis drug into Germany. 8 February 2018
Americas
Teva sued Eli Lilly yesterday in a bid to protect its IP rights covering “breakthrough treatments for migraine headaches”. 7 February 2018